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Abstract
Early identification of autism spectrum disorder (ASD) is regarded as crucial for swift access to early intervention and, 
subsequently, better outcomes later in life. However, current instruments miss large proportions of children who later go on 
to be diagnosed with ASD, raising a question of what these instruments measure. The present study utilized data from the 
Norwegian Mother, Father, and Child Cohort Study and the Autism Birth Cohort study to explore the subsequent devel-
opmental and diagnostic characteristics of children raising developmental concern on the six-critical discriminative item 
criterion of the M-CHAT (DFA6) at 18 months of age (N = 834). The DFA6 identified 28.8% of children diagnosed with 
ASD (N = 163), but 4.4% with language disorder (N = 188) and 81.3% with intellectual disability (N = 32) without ASD. 
Scoring in the «at-risk» range was associated with lower IQ, impaired functional language, and greater severity of autism 
symptoms whether children had ASD or not.
Keywords MoBa · Norwegian mother · Father and child cohort study · Cognition · Language · Autism spectrum disorders · 
Vineland · ADOS · Screening · Early identification
Introduction
Early identification of autism spectrum disorder (ASD) 
is regarded as crucial for prompt access to early interven-
tion, and subsequently, better outcomes later in life (Fernell 
et al. 2013; Mandell et al. 2005; Zwaigenbaum et al. 2015). 
Recent studies have revealed that only a small proportion of 
young children, between 18 and 36 months of age, eventu-
ally diagnosed with an autism spectrum disorder (ASD) are 
captured by screening instruments (Guthrie et al. 2019; Øien 
et al. 2018b; Stenberg et al. 2014; Surén et al. 2019). Thus, 
it is essential to determine if children who are diagnosed 
early show different behavioral characteristics compared to 
children who are missed. A better understanding of these 
characteristics may allow providers to identify early inter-
ventions that are best suited to a children’s specific needs 
(Fernell et al. 2013).
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Currently, a range of autism-specific screening meas-
ures exist that probe for early developmental and behavioral 
delays or deviancies. The Modified Checklist for Autism in 
Toddlers (M-CHAT) (Kleinman et al. 2008; Robins et al. 
2001) and subsequent M-CHAT Revised with Follow-Up 
(M-CHAT-R/F) (Robins et al. 2014) are currently the most 
studied screening instruments for children younger than 
36 months. However, studies reveal that the M-CHAT fails 
to identify the majority of 18-month-olds who are later diag-
nosed with ASD (Guthrie et al. 2019; Øien et al. 2018a; 
Stenberg et al. 2014; Sturner et al. 2017). One possible cause 
of the discrepancy in findings may be that measures imple-
mented in the M-CHAT-R/F aimed to reduce false positives, 
not to increase the identification of false negatives (Øien 
et al. 2018a; Stenberg et al. 2014). Additionally, many stud-
ies using the M-CHAT and M-CHAT-R/F in large samples 
only validate the screening results with a full assessment 
of the screen positives for ASD (Chlebowski et al. 2013; 
Kleinman et al. 2008; Pandey et al. 2008; Robins et al. 
2001, 2014). As a result, these studies are unable to capture 
false negatives because few screen negatives are reassessed 
between 18 and 24 months of age, and even fewer are fol-
lowed later to examine diagnostic status and developmental 
trajectories.
While the primary rationale for screening is to improve 
early identification and facilitate swift access to interven-
tion, most screening-related efforts have had a limited effect 
on decreasing the age of diagnosis. Despite many parents 
expressing concerns when children are 15 months of age 
or younger (Chawarska et al. 2006), recent epidemiologi-
cal studies report that the average age of diagnosis remains 
between 3 and 5 years (Baio 2012; Baio et al. 2018; Foun-
tain et al. 2011; Mandell et al. 2010; Surén et al. 2019). 
Further research is needed to delineate the differences in 
early behavioral characteristics, developmental trajectories, 
and age of parental concern in early- versus late-diagnosed 
children with ASD in the general population.
It is essential to address the sparsity of knowledge regard-
ing the variability in developmental and behavioral charac-
teristics of 18-month-old children who are later diagnosed 
with ASD. A minority of these children meet the threshold 
to be considered as "at-risk” at 18 months based on screen-
ing instruments (Stenberg et al. 2014). It is particularly 
unclear how the phenotypic presentations of these “at-risk” 
children later diagnosed with ASD differ from those of autis-
tic children who were not identified by gold-standard screen-
ing measures and who would hence have been considered as 
“low-risk” at 18 months (Beacham et al. 2018; Øien et al. 
2018a). Increased knowledge of phenotypic differences asso-
ciated with screening performance and outcomes is critical 
for addressing the challenges of identifying a more substan-
tial proportion of children at 18 months that later go on to 
develop ASD. This is especially true for those children who 
are not identified by the currently used core symptom pat-
terns expected at 18 months as concurrent or emerging early 
markers for ASD.
The current knowledge gap is related to the understanding 
of the association between broader behavioral and devel-
opmental characteristics of children at the time of screen-
ing, and later developmental outcomes in those identified 
prospectively with ASD. Because most screening studies 
are conducted in high-risk samples, less is known about 
the expression of children missed by screening instruments 
(i.e., children regarded as "low-risk" after initial screening 
but receiving a diagnosis later). Understanding which early 
behavioral and developmental symptoms characterize chil-
dren who are missed in early screening provides a basis for 
improving ASD screening instruments and can substantially 
increase their efficiency in identifying children as early as 
18 months of age who are on a path of being diagnosed with 
ASD. For example, some studies, such as studies of infant 
siblings of children with ASD, have found that early devel-
opmental characteristics (fine motor skills at six months) 
predicted the severity of ASD symptoms both at 18 and 
36 months of age (Iverson et al. 2019). Other studies have 
found that combining a screening instrument with a general 
developmental checklist improved the prediction of a later 
ASD diagnosis (Beacham et al. 2018).
Finally, it is crucial to understand whether screening 
instrumssents can identify children who are later diagnosed 
with neurodevelopmental disorders other than ASD (i.e., 
false positives). Children with more advanced language 
skills and IQ within the average range might make some 
toddlers appear more typical. These toddlers often do not 
meet the threshold for parental or professional concern and, 
because little is known about the heterogeneity of predictive 
symptoms of ASD, they are more challenging to identify as 
at-risk for ASD (Øien et al. 2018a; Salomone et al. 2015; 
Surén et al. 2019). However, there may be other symptom 
patterns associated with the development of ASD that have 
yet to be explored in screener development (Chawarska et al. 
2014). It is crucial to understand more about the develop-
mental and behavioral characteristics that predict ASD diag-
nosis and ASD subgroup identification so that we may tailor 
screening instruments and increase the performance of early 
identification. This could enable researchers to identify dif-
ferent subgroups of children later diagnosed with ASD, but 
who do not early show the types of symptoms enlisted in the 
current screening instruments.
The aims of the current study are to:
(1) compare child characteristics at the time of clinical 
diagnostic assessment and relate those to the presence 
(at-risk) or absence (low-risk) of core ASD symptoms 
at 18 months, i.e., including both children with early 
symptoms who were later diagnosed with ASD (true 
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positives), and children with no symptoms, but who 
were still diagnosed with ASD later (false negatives).
(2) compare developmental characteristics at the clinical 
assessment of children with and without ASD depend-
ing on whether they rated above or below the threshold 
for concern on core ASD symptoms at 18 months. The 
four groups (true positives, true negatives, false posi-
tives, and false negatives) are compared on measures 
of (a) cognition (IQ), (b) functional language (Vineland 
Adaptive Behavior Scales; Communication Domain), 
and c) ASD symptom severity (ADOS CSS) at the time 
of clinical assessment.
(3) examine whether the core symptoms (as measured by 
the screening instrument) for ASD are specific to ASD, 
or whether measures screening for these symptoms 
also characterize children with other neurodevelop-
ment diagnoses, i.e., detailing the diagnostic outcome 
of false positives and false negatives.
Methods
Participants
The present study utilizes data collected in the Autism Birth 
Cohort study (ABC study) (Stoltenberg et al. 2010). The 
ABC Study is a sub-study of the Norwegian Mother, Father, 
and Child Cohort Study (MoBa) (Magnus et al. 2016) aim-
ing to identify all ASD cases within MoBa (Surén et al. 
2019). MoBa is a national prospective general population 
pregnancy cohort conducted by the Norwegian Institute 
of Public Health. Participants were recruited from all over 
Norway between 1999 and 2008. The women consented to 
participation in 41% of the pregnancies and included 114, 
552 children, 95,000 mothers, and 75,200 fathers (Magnus 
et al. 2016). Parents who agreed to participate in MoBa and 
the ABC Study signed an informed consent form, and the 
study was approved by the Regional Committee for Medical 
and Health Research Ethics South East. MoBa data version 
9 was used.
The mothers completed questionnaires during pregnancy 
and at regular intervals after birth, at 6, 18, and 36 months 
as well as at 5, 7, 8, and 14 years (still ongoing). The MoBa 
questionnaires include items on child development and 
behavior as well as health, diet, socioeconomic factors, and 
other factors relevant to child and parental health. Parents 
completed the questionnaires independently, without assis-
tance from a health care professional. The clinical assess-
ments in the ABC study started in 2005 and ended in 2012, 
finalizing the assessment of 1,033 children. Since the end 
of the clinical assessments, the ABC sample is followed 
through yearly linkage to the Norwegian Patient Registry 
(NPR), a national registry containing information about all 
discharge diagnoses on children who were referred to spe-
cialized health services. The study has information about 
discharge diagnosis from 2008 through 2015.
Recruitment of the Sample
Multiple methods identified potential cases of ASD seen in 
the ABC study clinic, including MoBa questionnaire infor-
mation (at child age 3, 5, and 7 years), referrals (parental or 
professional), and annual linkages to the Norwegian Patient 
Register (NPR). The clinical study focused primarily on 
assessing 3-year-olds and utilized six questionnaire-based 
selection criteria from the 3-year-old questionnaire in MoBa 
(Q3yr). The selection criteria cast the screening net wide to 
ensure that all children on the path to a diagnosis of ASD 
would be captured.
Families endorsing any of the following six specific cri-
teria were invited for a clinical assessment: (Criterion 1) 
Families of children scoring at or above a cutoff of 12 on 
the Social Communication Questionnare (SCQ) embedded 
in Q3yr (see details on the study-specific screening proce-
dures in Stoltenberg et al. 2010, pp.677–678). (Criterion 2) 
Families of children endorsed on all nine repetitive behav-
ior items on the SCQ. (Criterion 3) Families who reported 
language delay under the “health problem” section in Q3yr 
and referred to a language specialist. (Criterion 4) Families 
who reported "yes" on autism or autistic traits under the 
"health problem” section in Q3yr, and/or “yes” on autism/
Asperger syndrome in Q5yr or Q7yr “health problem” sec-
tion. (Criterion 5) Families who reported concerns about the 
child’s lack of interest in playing with other children under 
the “concern about the child” section. (Criterion 6) Fami-
lies who reported that others (e.g. family, day-care staff, and 
well-baby nurses) had expressed concern about the child’s 
development. In addition to the specific criteria based on 
the 3-year-old questionnaire, both professionals and parents 
could refer a child with suspected ASD to the study if the 
family/child were participating in MoBa and the child was 
born in the same time interval as the questionnaire-recruited 
children in the study.
Among the 1033 children clinically assessed in the ABC 
study, 665 were children who met one or more of the high-
risk criteria listed above. The remaining 368 comprised 
the random control group and were drawn from the same 
cohort in a nested case–control design. For details on the 
ABC study criteria and results, see (Stoltenberg et al. 2010) 
and (Surén et al. 2019). After the research clinic ended in 
2012, case ascertainment has continued through annual link-
age to the NPR. At the last linkage in 2015, only 56 ASD 
cases were detected through the screening effort and clinical 
assessments. The vast majority of children with ASD were 
detected through the registry linkage after the clinical study 
had ended (Surén et al. 2019).
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Study Sample
This study takes advantage of the data collected in the ABC 
study and focuses primarily on the early developmental his-
tory of children who were diagnosed with ASD either in the 
ABC clinic or later through NPR linkage (the last linkage 
was done in 2015). The 18-month questionnaire in MoBa 
contained the complete M-CHAT checklist and was com-
pleted long before the ABC study started, and no criteria 
from this questionnaire were used in the ABC study. Chil-
dren included in the final study sample had parents who (a) 
participated in the ABC study and returned the 18-month 
questionnaire, and (b) completed all of the six most discrimi-
native items from the M-CHAT (Robins et al. 2001). The 
six discriminative items have better psychometric properties 
compared to the full M-CHAT in terms of sensitivity and 
specificity in identifying children with ASD based on their 
early symptom patterns (Kleinman et al. 2008; Øien et al. 
2018a; Pandey et al. 2008; Stenberg et al. 2014). Totaling 
834 children, the sample consisted of 539 with potential 
ASD (81.1% of the potential ASD assessed in the clinic) 
and 295 random controls (80.2% of controls assessed in 
the clinic). 547 children were males (65.6%), and 163 were 
diagnosed with ASD through ABC’s clinical assessment or 
linkage to NPR.
Clinical Diagnosis
ASD diagnoses: The children were assessed in the ABC 
study clinic by a research-trained team of experienced clini-
cians (specialists in clinical psychology or child psychiatry). 
Children were rendered a best-estimate diagnosis according 
to the Diagnostic and Statistical Manual of Mental Disor-
ders, Fourth Edition, Text Revision (DSM-IV-TR) utilizing 
all available information from the clinical assessment. ASD 
symptoms were evaluated using the Autism Diagnostic Inter-
view-Revised (ADI-R) and the Autism Diagnostic Observa-
tion Schedule-Generic (ADOS-G) (Lord et al. 2000). No 
information from MoBa questionnaires or NPR was avail-
able for the research team concerning individual children, 
i.e., they were blinded to health differences, developmental 
questions, parental concern, and selection criteria. A diag-
nostic summary meeting among the research staff after the 
data collection integrated all available clinical information, 
and the diagnosis was rendered, along with the certainty of 
the conclusion.
Measures
Modified Checklist for Autism in Toddlers
The Modified Checklist for Autism in Toddlers (M-CHAT) 
(Robins et al. 2001) is the most widely used instrument for 
detecting early symptoms of ASD in young children (Ibaez 
et al. 2014), designed to be completed in the waiting room 
by a primary care provider (Robins et al. 2001). It has been 
recommended for use in toddlers at 18 months of age with a 
follow-up at 24 months (Bright Futures Steering Committee 
2006). This instrument is the best-validated measure of early 
ASD signs and symptoms. Scores depend on either a six-
critical discriminative item criterion (DFA6) or a total-23 
item criterion (Total23). The six-critical item criterion is met 
when failing two or more of the six critical items, whereas 
the Total23 criterion demands a failure of three or more of 
any of the 23 items of the M-CHAT. It is recommended to 
do a follow-up phone interview of screen positives to reduce 
the number of false positives. Since the introduction of the 
M-CHAT in 2001, a revision of the checklist was released in 
2014 (Robins et al. 2014), still used with the recommended 
follow-up interview to further reduce the number of false 
positives. The ABC study did not use any follow-up phone 
interviews in their design, as it is an epidemiological study, 
while the current study focuses on the relationship between 
early symptom patterns and later functional outcome both in 
children with and without ASD. Failing two or more of the 
six critical items at 18 months is treated as consistent report-
ing of core ASD symptoms (i.e., being at-risk). It is not an 
indication that such a child would be diagnosed with ASD 
this early, even if an experienced autism specialist evaluated 
the child at 18 months.
Cognitive Skills
Children’s cognitive level was assessed with an appropriate 
developmental test, depending on age and cognitive level. As 
a general rule, the Stanford-Binet Intelligence Scales: Fifth 
Edition (SB-5) (Roid and Pomplun 2012) was the first choice 
for all children younger than 6 years of age. The SB-5 Brief 
IQ score (based on two routing-tasks from verbal and non-
verbal domains) was calculated if the child did not complete 
all the subtests. If the child was not able to complete the 
routing tasks on the SB-5, a switch was made to the Mullen 
Scales of Early Learning (MSEL) (Mullen 1995). For chil-
dren who were 6 years or older at clinical assessment, the 
Wechsler Abbreviated Scale of Intelligence (WASI) (Psy-
chological Corporation 1999) was used, and the SB-5 was 
administered if the child was not able to complete WASI.
Communication Skills
The Vineland Adaptive Behavior Scales (VABS, 2nd edi-
tion) (Sparrow et al. 2005) is a parent interview assess-
ing adaptive skills in four domains, communication, daily 
living, socialization, and motor. In the current study, the 
VABS Communication Domain was used to assess language 
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ability, including expressive, receptive, and literacy skills. 
The standardized score for each domain was used.
Symptom Severity of ASD
The Autism Diagnostic Observation Schedule (ADOS-G) 
is a semi-structured play- and conversation-based assess-
ment. Module 1, 2, or 3 was administered depending on the 
child’s level of expressive language. The revised algorithm 
and calibrated severity scores described by Gotham and col-
leagues (Gotham et al. 2006) were used because they are 
better suited than the original algorithm scores for compar-
ing ADOS scores across modules. The revised algorithm 
calculates ADOS summary scores for social and repetitive 
behavior domains. The calibrated severity scores are less 
influenced by age and language level than are raw scores 
(Gotham et al. 2008).
Statistical Analyses
Pearson’s chi-squared test (when appropriate) were used to 
ascertaining between-group differences concerning parent 
characteristics and age of children. To compare children with 
ASD with and without core ASD symptoms at 18 months 
to non-ASD children with and without core ASD symptoms 
at 18 months, on cognition, functional language and ASD 
symptom severity, a dummy variable (4 groups) was cre-
ated combining ASD diagnosis (yes/no) and risk status at 
18 months (yes/no). Children in the four groups were com-
pared on (a) cognition (IQ), (b) functional language (VABS), 
and (c) ASD symptom severity (ADOS-CSS) by conducting 
a one-way ANOVA with Bonferroni correction for post-hoc 
analyses (see Table 1). All statistical analyses were per-
formed using SPSS 26.
Results
Of the 163 children diagnosed with ASD in the ABC study/
NPR linkage, 47 (28.8%) met cut-off or above on DFA6 at 
18 months according to early ASD symptoms (at-risk, group 
D) compared to 116 children with ASD scoring below cut-
off according to early ASD symptoms (low-risk, group C). 
Comparable numbers in the non-ASD group were 59 (8.8%) 
who met cut-off on DFA6 at 18 months (at-risk, group B) 
compared to 612 children in the non-ASD group scoring 
below the cut-off (low-risk, group A). There were signifi-
cant between-group differences in the proportion of children 
reaching cut-off on DFA6 across age and sex (see Table 2). 
In all four groups (A to D), the majority reaching cut-off 
were boys. The ratio of boys to girls in the ASD groups 
(C, D) was approximately 7: 1 in the low-risk group and 
approximately 1.5: 1 in the at-risk group. The comparable 
ratio in the non-ASD groups (A, B) was 1.5: 1 in the low-risk 
group and approximately 5.0: 1 in the at-risk group.
There were no significant between-group differences 
related to maternal age, maternal education, or parity 
(see Table 3). Subsequent analyses were conducted on all 
children (with/without ASD) regardless of risk status at 
18 months. This was done to identify child characteristics, 
possibly contributing to the determination of risk status.
Cognition
Analysis of IQ score at the time of clinical assessment 
indicated a significant association between 18 months risk 
status (at-risk/low-risk according to whether early ASD 
symptoms were present or absent) and later cognitive 
skills (F (3, 816) = 133,749, p < 0.001). Post-hoc analysis 
Table 1  Child test characteristic across child diagnosis and screening status on DFA6 from M-CHAT
All differences significant except group B vs. C on VABS functional language
a WASI, SB-5 or Mullen scales of early development
b Vineland Adaptive Behaviour Scale—communication domain
c Autism diagnostic observation schedule 4 N in each group varies due to missing data on outcome measures (from 1 to 8 children missing)










Below cut off Cut off or higher Below cut off Cut off or higher
Mean (SD)
 IQa 100.2 (14.1) 73.2 (20.7) 87.9 (20.4) 60.2 (15.3) 133.75*  < .001
 VABSb func-
tional language
95.9 (12.5) 73.2 (15.4) 78.4 (17.2) 61.0 (13.2) 165.54*  < .001
 ADOSc CSS 1.4 (1.1) 2.7 (2.2) 5.2 (2.5) 6.1 (2.7) 284.10*  < .001
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revealed that children with at-risk status at 18 months 
had lower IQ scores at the time of assessment compared 
to low-risk children, both in the ASD group and non-
ASD group. The mean difference in IQ between children 
below DFA6 cut-off compared to those scoring at cut-off 
or above were  Mdiff = 27.7, CI95% (20.2, 35.2) IQ points 
in the ASD group, and  Mdiff = 26.9, CI95% (21.0, 32.7) 
in the non-ASD group. Children diagnosed with ASD 
and scoring below cut-off on DFA6 at 18 months (low-
risk) had a mean IQ score at the assessment of M = 87.9, 
CI95% (84.0, 91.7) compared to children with ASD who 
scored at or above cut-off with M = 60.2, CI 95% (55.7, 
64.7). This indicates an association between showing core 
ASD symptoms (at-risk) at 18 months and a lower cogni-
tive level (IQ measure) at the time of assessment.
Table 2  Child age and sex across child diagnosis and screening status on DFA6 from M-CHAT
a Fisher’s exact test (expected number in cells < 5)










Below cut off Cut off or higher Below cut off Cut off or higher
Age at 
assessment
3 and 4 years 587 (95.9%) 57 (96.6%) 60 (51.7%) 40 (85.1%) 211.488a  < .001
5 and 6 years 13 (2.1%) 2 (3.4%) 17 (14.7%) 3 ( 6.4%)
7 to 10 years 12 (2.0%) 0 (0.0%) 39 (33.6%) 4 (8.5%)
Sex Male 367 (60.0 &) 49 (83.1%) 101 (87.1%) 30 (63.8%) 40.318 4  < .001
Female 245 (40.0%) 10 (16.9%) 15 (12.9%) 17 (36.2%)
Table 3  Parental characteristics across child diagnosis and symptom status on DFA6 from M-CHAT
Fisher’s exact test or Pearson’s Chi-squared test
a Rated with none or only one ASD symptom
b Not completed high school
c High school level
d Bachelor level
e Master/Ph.D. level










Below cut  offa Cut off or higher Below cut off 0 Cut off or higher
Maternal age < 25 years 57 (9.3%) 6 (10.2%) 15 (12.9%) 2 (4.3%) χ2 = 13.916  = .125
25–29 years 185 (30.2%) 12 (20.3%) 39 (33.6%) 22 (46.8%)
30–34 years 240 (39.2%) 28 (47.5%) 46 (39.7%) 16 (34.0%)
> 34 years 130 (21.2%) 13 (22.0%) 16 (13.8%) 7 (14.9%)
Maternal education < 12  yearsb 42 (6.9%) 8 (13.6%) 7 (6.0%) 6 (12.8%) χ2 = 11.607  = .478
12  yearsc 153 (25.0%) 14 (23.7%) 38 (32.8%) 13 (27.7%)
13–16  yearsd 241 (39.4%) 24 (40.7%) 44 (37.9%) 16 (34.0%)
> 17  yearse 160 (26.1%) 11 (18.6%) 25 (21.6%) 12 (25.5%)
Missing 16 (2.6%) 2 (3.4%) 2 (1.7%) 0 (0.0%)
Parity 0 281 (45.9%) 23 (39.0%) 67 (57.8%) 25 (53.2%) χ2 = 7.839  = .049
1+ 331 (54.1%) 36 (61.0%) 49 (42.2%) 22 (46.8%)
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Functional Language
Analyses using standardized scores of functional language 
(VABS) at the time of assessment indicated a significant 
association of risk status (at-risk/low-risk on presence/
absence of early ASD symptoms) and later functional 
language skills (F (3, 795) = 165,537, p < 0.001). Post-
hoc analysis revealed that children with at-risk status at 
18 months, in general, had lower standardized VABS func-
tional language scores at the time of assessment compared 
to low-risk children, both in the ASD group and non-ASD 
group. The mean difference in functional language score 
between children scoring below DFA6 cut-off compared to 
those scoring at cut-off or above was  Mdiff = 17.4, CI95% 
(11.2, 23.7) in the ASD group, and  Mdiff = 22.7, CI95% 
(17.7, 27.7) in the non-ASD group. Children diagnosed with 
ASD and scoring below cut-off on DFA6 at 18 months (low-
risk) had a mean functional language score at the assessment 
of M = 78.4, CI95% (75.1, 81.6) compared to children with 
ASD who scored at or above cut-off with M = 61.0, CI95% 
(55.7, 64.7). This indicates an association between show-
ing core ASD symptoms at 18 months (at-risk) and lower 
functional language skills (VABS) at the time of assessment.
ADOS Calibrated Severity Score (ADOS CSS)
Analyses of ADOS symptom severity score at the time 
of assessment indicated a significant association between 
risk status (at-risk/low-risk on presence/absence of 
early ASD symptoms) and later symptom severity (F (3, 
825) = 284,101, p < 0.001). Post-hoc analysis revealed that 
children with at-risk status at 18 months, had higher symp-
tom severity scores at the time of assessment compared to 
low-risk children, both in the ASD group and non-ASD 
group. The mean difference in symptom severity score 
between children scoring below DFA6 cut-off compared to 
those scoring at cut-off or above were  Mdiff = − 1.0, CI95% 
(− 1.7, − 0.2) in the ASD group and  Mdiff = − 1.3, CI95% 
(− 1.8, − 0.7) in the non-ASD group. Children diagnosed 
with ASD and scoring below cut-off on DFA6 at 18 months 
(low-risk) had a mean symptom severity score at the assess-
ment of M = 5.2, CI95% (4.7, 5.6) compared to children 
with ASD who scored at or above cut-off with M = 6.1, CI 
95% (5.3, 6.9). This indicates an association between show-
ing core ASD symptoms at 18 months (at-risk) and higher 
symptom severity (ADOS-CSS) at the time of assessment.
Other Diagnoses
The DFA6 did not capture the majority of children at 
18 months who were diagnosed with ASD at the clinical 
assessment in the ABC study or from the NPR registry. 
Thirty percent of the children diagnosed with Autistic Disor-
der (non-syndromic) did show ASD symptoms at 18 months 
(at-risk), compared to 22% of those later diagnosed with 
Asperger syndrome or PDD-NOS at the ABC clinic or in 
NPR. Seven children identified with ASD in the clinic had 
a concurrent known syndrome combined with severe intel-
lectual disability (N = 5) or had a history of loss of skills 
(disintegrative disorder) (N = 2). The two children with 
loss of skills scored, as expected, below cut-off on DFA6 at 
18 months, and the other five ("syndromic ASD") scored at 
or above cut-off on the DFA6 criterion. To further explore 
the characteristics of children identified by the DFA6, we 
also looked at the distribution (below cut-off/above cut-off 
on DFA6) across other relevant diagnoses in the sample, 
e.g., specifically children diagnosed with language impair-
ment or with intellectual disability (Table 4).
The clinical sample comprised of 32 children with a 
primary diagnosis of Intellectual Disability. Most of these 
children (N = 26; 81.3%) scored above the six critical item 
criteria (DFA6). However, in the group of children with a 
primary diagnosis of Language Impairment at assessment, 
only approximately one in twenty children (N = 23; 4.4%) 
scored at or above the DFA6 cut-off at 18 months. In chil-
dren with no diagnoses or clinical problems, only three 
scored at or above the six critical item criteria (DFA6) of 
Table 4  Diagnostic result across 
screening status on DFA6 from 
M-CHAT
Dx diagnosis, ClinProbl clinical problems, ID intellectual disability, ASD autism spectrum disorder, LD 
language disorder
N (%) Below cut-off Cut-off or higher Total
No Dx or ClinProbl 288 3 (1.0%) 291
Autistic disorder 65 28 (30.1%) 93
PDD-Nos 49 14 (22.2%) 63
Syndrome ASD or loss of skills 2 5 (71.4%) 7
Intellectual disability (ID) no ASD 6 26 (81.3%) 32
Language disorder (LD) noASD noID 165 23 (4.4%) 188
Other Dx or ClinProbl 153 7 (4.4%) 160
Total 728 106 834
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two or more core ASD symptoms at 18 months (N = 3, 
1.0%).
Discussion
The present study compared intellectual level, functional 
language skills and ASD symptom severity at the age of 
diagnostic assessment (age range 3–10 years) with ASD at-
risk status at 18 months of age based on the symptom score 
on the six critical items of the M-CHAT (DFA6) and diag-
nostic outcomes in the ABC study/NPR (ASD, non-ASD). 
The results indicate an association between parents’ recog-
nition of clinical signs of ASD at 18 months (at or above 
cut-off on DFA6) and the severity of cognitive impairments 
in children with ASD at diagnostic assessment. Further-
more, children with ASD who showed core ASD symptoms 
at 18 months (at-risk) scored lower on functional language 
skills at the clinical assessment and with increased symptom 
severity (ADOS CSS) score compared to children with ASD 
who scored below cut-off on DFA6 (low-risk) at 18-months, 
as is also true for the non-ASD groups as well.
The finding that children with ASD who scored below 
the cut-off for ASD symptoms (DFA6) at 18 months scored 
within the average IQ range at assessment, and children 
with ASD who scored at or above the cut-off for core ASD 
symptoms at 18 months scored within the intellectual dis-
ability range, is consistent with previous reports. Early iden-
tification of ASD is associated with general developmen-
tal delay and more pronounced cognitive impairment than 
later identified children, suggesting that a more significant 
impairment is necessary to raise parental concerns as early 
as 18 months, or that early symptoms of ASD might be more 
heterogeneous than those often considered prototypical for 
ASD (Baghdadli et al. 2003; Chawarska et al. 2006, 2014; 
Giacomo & Fombonne 1998; Guthrie et al. 2019; Iverson 
et al. 2019; Øien et al. 2018a; Shattuck et al. 2009). Sev-
eral population-based studies show that a large proportion 
of children who later were diagnosed with ASD were not 
identified by screening instruments at 18 months (Baird et al. 
2000; Guthrie et al. 2019; Øien et al. 2018a; Stenberg et al. 
2014). It is likely that population-based samples, in contrast 
to clinical samples (or stage 2 screening), include more chil-
dren who are within the average range of IQ and functional 
language skills. Children referred for clinical assessment are 
likely to be more severely affected and have more prototypi-
cal symptoms than children in a general population-based 
sample. Additionally, in clinical samples, parents are already 
likely to express concern about their child’s development, 
which might influence how they answer questionnaires and 
rate symptom patterns. In line with this, commonly used 
screening instruments seem to perform more ‘accurately’ 
in high-risk samples (i.e., children referred for diagnostic 
assessment) than in low-risk samples (children attending 
routine visits to well-baby clinics) (Kleinman et al. 2008; 
Pandey et al. 2008). This suggests that the instruments are 
picking up children with ASD who have lower intellectual 
and adaptive functioning while missing children with more 
robust general intellectual development and better functional 
language (Eaves et al. 2016; Kamio et al. 2013; Øien et al. 
2018b; Salomone et al. 2015; Snow and Lecavalier 2008). 
In other words, the performance of screening instruments at 
an early age, as reported in many high-risk clinical samples, 
seems biased towards more severe behavioral characteristics 
of ASD and other atypical developmental phenomena.
Difficulties in identifying children with ASD early in 
the developmental period are related to the substantial het-
erogeneity that characterizes ASD (Ozonoff et al. 2010; 
Zwaigenbaum et al. 2015), affecting both the screening and 
the diagnostic process. Still, research suggests that ASD can 
be reliably diagnosed very early (Lord et al. 2006) and that 
early diagnoses of ASD are stable (Chawarska et al. 2007; 
Ozonoff et al. 2015). Another contributing factor is the pos-
sibility that a large proportion of children developing ASD 
do not show the prototypical signs of ASD at 18 months. 
ASD is a developmental disorder, and symptoms often 
emerge gradually. It is not known whether a different set 
of descriptors better captures key characteristics in children 
missed by current instruments or if the behavioral charac-
teristics of these children are more subtle and thus cannot 
meet actionable concern. Such challenges make it difficult to 
construct an appropriate checklist with the salient symptom 
description relevant at an early age for the whole spectrum of 
children with ASD (Øien, Schjølberg, et al. 2018a, b). There 
are indications that children need to show more significant 
impairment to be identified by screening instruments (Bagh-
dadli et al. 2003; Giacomo and Fombonne 1998; Shattuck 
et al. 2009). One possibility is that subgroups of children 
with ASD might show differences in developmental trajec-
tories throughout the first years of life, both in symptom 
pattern and in heterogeneity in age when features of autism 
begin to manifest and in a variation of when social demands 
exceed the child’s capabilities (Chawarska et al. 2006). The 
findings of the present study suggest that future research 
should focus on mapping the developmental trajectories of 
children with the aim of understanding factors that contrib-
ute to a child’s at-risk or low-risk status at various times in 
early development. Further, future research should aim to 
relate these findings to long-term outcome developmentally, 
behaviorally and diagnostically. Such knowledge might lead 
to the development of new methods and insights in early 
identification of children with lower symptom severity and 
cognitive impairment and to a better understanding of devel-
opmental processes underlying the emergence of autism fea-
tures in higher-functioning children with ASD at an early 
age. It is possible that broader developmental measures (e.g. 
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motor development and temperament) might prove useful 
and eventually contribute to a better understanding of the 
variability in early trajectories and hence contribute to a 
decrease in the age of diagnosis across the whole spectrum.
Findings from this study and other studies (Guthrie et al. 
2019; Øien et al. 2018a; Stenberg et al. 2014; Yuen et al. 
2018) warrant a meaningful discussion on the feasibility 
of universal screening at 18 months and give directions for 
moving to capture different phenotypical variants of autism 
spectrum disorder at an early age. In this study, the early at-
risk score was defined at 18 months based on the six critical 
items from M-CHAT and was related to diagnostic conclu-
sions several years later. It might be necessary to revisit our 
determination of prototypical early developmental features 
of ASD. One strategy for follow-up would be to utilize a 
broad set of assessment tools to capture characteristics and 
changes in behavior patterns across age and to look specifi-
cally at the developmental trajectories of children with ASD 
who have preserved language and intellectual abilities. The 
fact that some of these children are identified early, both by 
parents and professionals, should bring forward opportuni-
ties to study their development in greater detail. At present, 
studies indicate that finding one single measure to identify 
all ASD-relevant developmental profiles of delayed and 
deviant behavior in early childhood might be utopian at this 
point, and that such measures might be close to or impos-
sible to construct due to the heterogeneous nature of ASD. 
However, it is essential to follow the same goal-directed 
course as Robins and Colleagues on the M-CHAT and the 
later M-CHAT-R (Robins et al. 2001, 2014). Over almost 
two decades, they have provided the field with the measures 
that currently –in spite of their shortcomings– are regarded 
as the gold standard of screening instruments. In the end, 
the best approach to early identification may be to combine 
multiple measures and to consider parental concern as “red-
flags,” even when concern for prototypical signs of ASD are 
not present. As Mick Jagger and Keith Richards sing: “You 
can’t always get what you want” might also apply to the pos-
sibility of developing one measure to identify all children 
with ASD. It may be necessary to envision a gold standard, 
in terms of psychometric properties, for screening instru-
ments for early detection as relative rather than absolute 
(Øien et al. 2019).
Strengths and Limitations
Previous studies in the field of early identification of chil-
dren with ASD have mostly used clinical samples and retro-
spective data collection. The principal strength of this study 
is prospective data collection and information about signs of 
ASD before the diagnosis has been established. The MoBa 
cohort is population-based; thus, both children with mild and 
severe ASD symptoms are included in the study.
Only six items on ASD characteristics at 18 months were 
used for the analyses in the present study. In a previous 
study, we found that the three M-CHAT items that contrib-
uted to the highest likelihood ratios for ASD (the proportion 
of screen-positives among ASD cases relative to the propor-
tion of screen-positives among non-cases) were among these 
six items that had been found in other studies to be most 
critical for distinguishing ASD (Stenberg et al. 2014).
Most population-based studies are affected by selection 
bias. Compared with the Norwegian birth cohort, the MoBa 
cohort and the ABC Study cohort have an under-represen-
tation of young mothers (< 25 years), mothers who have 
single status, mothers who smoked during pregnancy, and 
non-users of prenatal folic acid supplements (Nilsen et al. 
2009, 2013).
Different methods were used to assess intellectual level 
due to the age span and different levels of intellectual abil-
ity in our sample. This is not optimal because different IQ 
measures are normed on different samples. However, the IQ 
difference between at-risk and low-risk 18-month-old chil-
dren in the current study was so substantial that we would 
not expect this to be an effect of the different IQ measures 
in of itself. All IQs were calculated based on US norms 
because Norwegian norms were not yet available for WASI, 
SB-5, or Mullen.
Acknowledgments Open Access funding provided by UiT The Arc-
tic University of Norway. The Norwegian Mother, Father and Child 
Cohort Study is supported by the Norwegian Ministry of Health and 
Care Services and the Ministry of Education and Research. We are 
grateful to all the participating families in Norway who take part in 
this on-going cohort study. The authors would like to acknowledge 
and thank all participating families and their children. Furthermore, we 
want to acknowledge the help of Madeline Aubertine, Minhang Xie, 
and Katherine Riley of the Seattle Children’s Research Institute in the 
editing process of this article.
Author Contributions NS, SS, and RAØ designed and conducted the 
analyses, drafted the manuscript and revised according to input from 
co authors. FS, FRV, ASØ, MB, BKS, SvT, DVC, KC, PS, and NTT 
reviewed, revised and provided input and editing of the manuscript. All 
authors approved the final submission.
Compliance with Ethical Standards 
Conflict of interest The Autism Birth Cohort Study is funded by 
the National Institute of Neurological Disorders and Stroke (NIH/
NINDS), Bethesda, MD, USA (Grant No. NS47537). The Norwegian 
Mother and Child Cohort Study is funded by the Norwegian Ministry 
of Health and Care Services, the Norwegian Ministry of Education 
and Research, the Research Council of Norway / FUGE (Grant No. 
151918), the National Institute of Neurological Disorders and Stroke 
(NIH/NINDS), Bethesda, MD, USA (Grant No. NS47537), and the 
National Institute of Environmental Health Sciences (NIH/NIEHS), 
Research Triangle Park, NC, USA (Contract No. NO-ES-75558). The 
present study was supported by a grant from the Research Council of 
Norway (Grant No. 196452). The authors report no conflicts of inter-
est.
 Journal of Autism and Developmental Disorders
1 3
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
Baghdadli, A., Picot, M. C., Pascal, C. L., Pry, R., & Aussilloux, C. 
(2003). Relationship between age of recognition of first distur-
bances and severity in young children with autism. European 
Child & Adolescent Psychiatry, 12(3), 122–127. https ://doi.
org/10.1007/s0078 7-003-0314-6.
Baird, G., Charman, T., Baron-Cohen, S., Cox, A., Swettenham, J., 
Wheelwright, S., et al. (2000). A screening instrument for autism 
at 18 months of age: A 6-year follow-up study. Journal of the 
American Academy of Child & Adolescent Psychiatry, 39(6), 
694–702.
Baio, J. (2012). Prevalence of autism spectrum disorders: Autism and 
developmental disabilities monitoring network, 14 Sites, United 
States, 2008. Morbidity and Mortality Weekly Report. Surveil-
lance Summaries, 61(3).
Baio, J., Wiggins, L., Christensen, D., Maenner, M., Daniels, J., 
Warren, Z., et al. (2018). Prevalence of autism spectrum disor-
der among children aged 8 years—Autism and Developmental 
Disabilities Monitoring Network, 11 Sites, United States, 2014. 
Morbidity and Mortality Weekly Report. Surveillance Summaries, 
67(6), 1–23. https ://doi.org/10.15585 /mmwr.ss670 6a1.
Beacham, C., Reid, M., Bradshaw, J., Lambha, M., Evans, L., Gillespie, 
S., et al. (2018). Screening for Autism Spectrum Disorder: Pro-
files of Children Who are Missed. Journal of Developmental 
and Behavioral Pediatrics: JDBP, 39(9), 673–682. https ://doi.
org/10.1097/dbp.00000 00000 00060 7.
Bright Futures Steering Committee. (2006). Identifying infants and 
young children with developmental disorders in the medical home: 
An algorithm for developmental surveillance and screening. Pedi-
atrics, 118(1), 405–420. https ://doi.org/10.1542/peds.2006-1231.
Chawarska, K., Klin, A., Paul, R., & Volkmar, F. (2007). Autism spec-
trum disorder in the second year: Stability and change in syn-
drome expression. Journal of Child Psychology and Psychiatry, 
48(2), 128–138. https ://doi.org/10.1111/j.1469-7610.2006.01685 
.x.
Chawarska, K., Paul, R., Klin, A., Hannigen, S., Dichtel, L. E., & Volk-
mar, F. (2006). Parental recognition of developmental problems in 
toddlers with autism spectrum disorders. Journal of Autism and 
Developmental Disorders, 37(1), 62–72. https ://doi.org/10.1007/
s1080 3-006-0330-8.
Chawarska, K., Shic, F., Macari, S., Campbell, D. J., Brian, J., Landa, 
R., et al. (2014). 18-month predictors of later outcomes in younger 
siblings of children with autism spectrum disorder: A baby sib-
lings research consortium study. Journal of the American Acad-
emy of Child & Adolescent Psychiatry, 53(12), 1317–1327. https 
://doi.org/10.1016/j.jaac.2014.09.015.
Chlebowski, C., Robins, D. L., Barton, M. L., & Fein, D. (2013). Large-
scale use of the modified checklist for autism in low-risk tod-
dlers. Pediatrics, 131(4), e1121–e1127. https ://doi.org/10.1542/
peds.2012-1525.
Eaves, L. C., Wingert, H., & Ho, H. H. (2016). Screening for autism: 
Agreement with diagnosis. Autism, 10(3), 229–242. https ://doi.
org/10.1177/13623 61306 06328 8.
Fernell, E., Eriksson, M. A., & Gillberg, C. (2013). Early diagnosis 
of autism and impact on prognosis: A narrative review. Clinical 
Epidemiology, 5(1), 33–43. https ://doi.org/10.2147/clep.s4171 4.
Fountain, C., King, M., & Bearman, P. (2011). Age of diagnosis for 
autism: Individual and community factors across 10 birth cohorts. 
Journal of Epidemiology and Community Health, 65(6), 503–510. 
https ://doi.org/10.1136/jech.2009.10458 8.
Giacomo, A. D., & Fombonne, E. (1998). Parental recognition of 
developmental abnormalities in autism. European Child & Ado-
lescent Psychiatry, 7(3), 131–136. https ://doi.org/10.1007/s0078 
70050 058.
Gotham, K., Pickles, A., & Lord, C. (2008). Standardizing ADOS 
scores for a measure of severity in autism spectrum disorders. 
Journal of Autism and Developmental Disorders, 39(5), 693–705. 
https ://doi.org/10.1007/s1080 3-008-0674-3.
Gotham, K., Risi, S., Pickles, A., & Lord, C. (2006). The autism diag-
nostic observation schedule: Revised algorithms for improved 
diagnostic validity. Journal of Autism and Developmental Disor-
ders, 37(4), 613–627. https ://doi.org/10.1007/s1080 3-006-0280-1.
Guthrie, W., Wallis, K., Bennett, A., Brooks, E., Dudley, J., Ger-
des, M., et al. (2019). Accuracy of autism screening in a large 
pediatric network. Pediatrics, 144(4), e20183963. https ://doi.
org/10.1542/peds.2018-3963.
Ibaez, L. V., Stone, W. L., & Coonrod, E. E. (2014). Screening for 
autism in young children Handbook of autism and pervasive 
developmental disorders (4th ed.). New York: Wiley.
Iverson, J. M., Shic, F., Wall, C. A., Chawarska, K., Curtin, S., Estes, 
A., et al. (2019). Early motor abilities in infants at heightened 
versus low risk for ASD: A Baby Siblings Research Consortium 
(BSRC) study. Journal of Abnormal Psychology, 128(1), 69–80. 
https ://doi.org/10.1037/abn00 00390 .
Kamio, Y., Inada, N., Koyama, T., Inokuchi, E., Tsuchiya, K., & 
Kuroda, M. (2013). Effectiveness of using the modified check-
list for autism in toddlers in two-stage screening of autism spec-
trum disorder at the 18-month health check-up in Japan. Journal 
of Autism and Developmental Disorders, 44(1), 194–203. https 
://doi.org/10.1007/s1080 3-013-1864-1.
Kleinman, J. M., Robins, D. L., Ventola, P. E., Pandey, J., Boorstein, 
H. C., Esser, E. L., et al. (2008). The modified checklist for 
autism in toddlers: A follow-up study investigating the early 
detection of autism spectrum disorders. Journal of Autism 
and Developmental Disorders, 38(5), 827–839. https ://doi.
org/10.1007/s1080 3-007-0450-9.
Lord, C., Risi, S., DiLavore, P. S., Shulman, C., Thurm, A., & Pickles, 
A. (2006). Autism from 2 to 9 years of age. Archives of Gen-
eral Psychiatry, 63(6), 694–701. https ://doi.org/10.1001/archp 
syc.63.6.694.
Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Leventhal, B. L., 
DiLavore, P. C., et al. (2000). The autism diagnostic observation 
schedule—Generic: A standard measure of social and communi-
cation deficits associated with the spectrum of autism. Journal of 
Autism and Developmental Disorders, 30(3), 205–223. https ://doi.
org/10.1023/a:10055 92401 947.
Magnus, P., Birke, C., Vejrup, K., Haugan, A., Alsaker, E., Daltveit, A. 
K., et al. (2016). Cohort profile update: The Norwegian mother 
and child cohort study (MoBa). International Journal of Epidemi-
ology, 45(2), 382–388. https ://doi.org/10.1093/ije/dyw02 9.
Mandell, D., Novak, M., & Zubritsky, C. (2005). Factors associated 
with age of diagnosis among children with autism spectrum dis-
orders. Pediatrics, 116(6), 1480–1486. https ://doi.org/10.1542/
peds.2005-0185.
Mandell, D., Morales, K., M.S., M., Lawer, L., Stahmer, A., & Marcus, 
S. (2010). Age of diagnosis among medicaid-enrolled children 
Journal of Autism and Developmental Disorders 
1 3
with autism, 2001–2004. Psychiatric Services, 61(8), 822–829. 
https ://doi.org/10.1176/ps.2010.61.8.822.
Mullen, E. M. (1995). Mullen scales of early learning (pp. 58–64). 
Circle Pines, MN: AGS.
Nilsen, R. M., Surén, P., Gunnes, N., Alsaker, E. R., Bresnahan, M., 
Hirtz, D., et al. (2013). Analysis of self-selection bias in a pop-
ulation-based cohort study of autism spectrum disorders. Paedi-
atric and Perinatal Epidemiology, 27(6), 553–563. https ://doi.
org/10.1111/ppe.12077 .
Nilsen, R. M., Vollset, S. E., Gjessing, H. K., Skjærven, R., Melve, 
K. K., Schreuder, P., et al. (2009). Self-selection and bias in a 
large prospective pregnancy cohort in Norway. Paediatric and 
Perinatal Epidemiology, 23(6), 597–608. https ://doi.org/10.111
1/j.1365-3016.2009.01062 .x.
Øien, R. A., Klin, A., Saulnier, C., Chawarska, K., McPartland, J. C., 
Nordahl-Hansen, A., et al. (2019). In memoriam: Domenic V. 
Cicchetti, PhD, 1937–2019. Journal of Autism and Developmen-
tal Disorders, 49(9), 3475–3476. https ://doi.org/10.1007/s1080 
3-019-04143 -5.
Øien, R. A., Schjølberg, S., Volkmar, F. R., Shic, F., Cicchetti, D. V., 
Nordahl-Hansen, A., et al. (2018a). Clinical features of children 
with autism who passed 18-month screening. Pediatrics, 141(6), 
e20173596. https ://doi.org/10.1542/peds.2017-3596.
Øien, R. A., Vambheim, S. M., Hart, L., Nordahl-Hansen, A., Erick-
son, C., Wink, L., et al. (2018b). Sex-differences in children 
referred for assessment: An exploratory analysis of the autism 
mental status exam (AMSE). Journal of Autism and Developmen-
tal Disorders, 48(7), 2286–2292. https ://doi.org/10.1007/s1080 
3-018-3488-y.
Ozonoff, S., Iosif, A. M., Baguio, F., Cook, I. C., Hill, M. M., Hutman, 
T., et al. (2010). A prospective study of the emergence of early 
behavioral signs of autism. Journal of the American Academy of 
Child & Adolescent Psychiatry, 49(3), 256–266.e2. https ://doi.
org/10.1016/j.jaac.2009.11.009.
Ozonoff, S., Young, G. S., Landa, R. J., Brian, J., Bryson, S., Charman, 
T., et al. (2015). Diagnostic stability in young children at risk 
for autism spectrum disorder: A baby siblings research consor-
tium study. Journal of Child Psychology and Psychiatry, 56(9), 
988–998. https ://doi.org/10.1111/jcpp.12421 .
Psychological Corporation. (1999). Wechsler abbreviated scale of intel-
ligence. San Antonio, TX: The Psychological Corporation.
Pandey, J., Verbalis, A., Robins, D. L., Boorstein, H., Klin, A., Babitz, 
T., et al. (2008). Screening for autism in older and younger tod-
dlers with the Modified Checklist for Autism in Toddlers. Autism, 
12(5), 513–535. https ://doi.org/10.1177/13623 61308 09450 3.
Robins, D. L., Casagrande, K., Barton, M., Chen, C.-M. A., Dumont-
Mathieu, T., & Fein, D. (2014). Validation of the modified check-
list for autism in toddlers, revised with follow-up (M-CHAT-
R/F). Pediatrics, 133(1), 37–45. https ://doi.org/10.1542/
peds.2013-1813.
Robins, D. L., Fein, D., Barton, M. L., & Green, J. A. (2001). The 
modified checklist for autism in toddlers: An initial study investi-
gating the early detection of autism and pervasive developmental 
disorders. Journal of Autism and Developmental Disorders, 31(2), 
131–144. https ://doi.org/10.1023/a:10107 38829 569.
Roid, G. H., & Pomplun, M. (2012). The stanford-binet intelligence 
scales. New York: The Guilford Press.
Salomone, E., Beranová, Š., Bonnet-Brilhault, F., Lauritsen, M. B., 
Budisteanu, M., Buitelaar, J., et al. (2015). Use of early inter-
vention for young children with autism spectrum disorder across 
Europe. Autism, 20(2), 233–249. https ://doi.org/10.1177/13623 
61315 57721 8.
Shattuck, P. T., Durkin, M., Maenner, M., Newschaffer, C., Mandell, 
D. S., Wiggins, L., et al. (2009). Timing of identification among 
children with an autism spectrum disorder: Findings from a popu-
lation-based surveillance study. Journal of the American Academy 
of Child & Adolescent Psychiatry, 48(5), 474–483. https ://doi.
org/10.1097/chi.0b013 e3181 9b384 8.
Snow, A. V., & Lecavalier, L. (2008). Sensitivity and specificity of the 
Modified Checklist for Autism in Toddlers and the Social Com-
munication Questionnaire in preschoolers suspected of having 
pervasive developmental disorders. Autism, 12(6), 627–644. https 
://doi.org/10.1177/13623 61308 09711 6.
Sparrow, S. S., Cicchetti, D. V., & Balla, D. A. (2005). Vineland 
adaptive behavior scales:(Vineland II), survey interview form/
caregiver rating form. Livonia, MN: Pearson Assessments.
Stenberg, N., Bresnahan, M., Gunnes, N., Hirtz, D., Hornig, M., Lie, K. 
K., et al. (2014). Identifying children with autism spectrum disor-
der at 18 months in a general population sample. Paediatric and 
Perinatal Epidemiology, 28(3), 255–262. https ://doi.org/10.1111/
ppe.12114 .
Stoltenberg, C., Schjølberg, S., Bresnahan, M., Hornig, M., Hirtz, D., 
Dahl, C., et al. (2010). The Autism Birth Cohort: A paradigm for 
gene-environment-timing research. Molecular Psychiatry, 15(7), 
676–680. https ://doi.org/10.1038/mp.2009.143.
Sturner, R., Howard, B., Bergmann, P., Morrel, T., Landa, R., Walton, 
K., et al. (2017). Accurate autism screening at the 18-month well-
child visit requires different strategies than at 24 months. Journal 
of Autism and Developmental Disorders, 47(10), 3296–3310. https 
://doi.org/10.1007/s1080 3-017-3231-0.
Surén, P., Saasen-Havdahl, A., Bresnahan, M., Hirtz, D., Hornig, M., 
Lord, C., et al. (2019). Sensitivity and specificity of early screen-
ing for autism. BJPsych Open, 5(3), e41. https ://doi.org/10.1192/
bjo.2019.34.
Yuen, T., Carter, M. T., Szatmari, P., & Ungar, W. J. (2018). Cost-
effectiveness of universal or high-risk screening compared to 
surveillance monitoring in autism spectrum disorder. Journal of 
Autism and Developmental Disorders, 48(9), 2968–2979.
Zwaigenbaum, L., Bauman, M. L., Fein, D., Pierce, K., Buie, T., Davis, 
P. A., et al. (2015). Early screening of autism spectrum disorder: 
Recommendations for practice and research. Pediatrics, 136(Sup-
plement), S41–S59. https ://doi.org/10.1542/peds.2014-3667d .
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
